NCT00404404View on ClinicalTrials.gov

ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer

PHASE2UnknownINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

October 31, 2006

Conditions

Breast Cancer

Interventions

BIOLOGICAL

bevacizumab

DRUG

paclitaxel albumin-stabilized nanoparticle formulation

Trial Locations (1)

90404

Premiere Oncology, Santa Monica

Sponsors

Lead Sponsor

Premiere Oncology

All Listed Sponsors

lead

Premiere Oncology

OTHER

NCT00404404 - ABI-007 and Bevacizumab in Treating Women With Recurrent or Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter